Clinical trial
A Pilot Randomised Comparison of Dexamethasone 96 mg Versus 16 mg Per Day for Malignant Spinal Cord Compression Treated by Radiotherapy
NCT00193869 is registered in ClinicalTrials.gov with Trans Tasman Radiation Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Randomised Comparison of Dexamethasone 96 mg Versus 16 mg Per Day for Malignant Spinal Cord Compression Treated by Radiotherapy
- Lead sponsor
- Trans Tasman Radiation Oncology Group
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 30, 2001
- Completion date
- December 31, 2003
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
spinal cord compression from neoplasm metastasis